2005
DOI: 10.1021/np050115m
|View full text |Cite
|
Sign up to set email alerts
|

SERCA-Inhibiting Activity of C-19 Terpenolides from Thapsia garganica and Their Possible Biogenesis

Abstract: An investigation of Thapsia garganica afforded a series of tetracyclic C-19 dilactones, whose production was dependent on the time and location of the collection. These unusual tetrahomosesquiterpenoids are presumably biosynthesized via a carbon dioxide-triggered electrophilic polyolefin cyclization. Despite the structural differences with thapsigargin, these compounds showed SERCA-inhibiting properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
50
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 46 publications
(50 citation statements)
references
References 10 publications
0
50
0
Order By: Relevance
“…The very tight binding of thapsigargin to all currently known SERCAs causes an irreversible inhibition that persists after removal of the excess inhibitor (Waldron et al, 1994), an observation that can explain, or contribute to, the potent apoptotic activity of this compound. Conversely, basiliolide A1 was unable to induce apoptosis in Jurkat cells, despite its alleged SERCA inhibitory activity (Appendino et al, 2005). It is therefore tempting to suggest that basiliolide A1 acts as a reversible SERCA inhibitor, not unlike 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a SERCA blocker that protects HeLa cells from ceramide-induced apoptosis (Pinton et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…The very tight binding of thapsigargin to all currently known SERCAs causes an irreversible inhibition that persists after removal of the excess inhibitor (Waldron et al, 1994), an observation that can explain, or contribute to, the potent apoptotic activity of this compound. Conversely, basiliolide A1 was unable to induce apoptosis in Jurkat cells, despite its alleged SERCA inhibitory activity (Appendino et al, 2005). It is therefore tempting to suggest that basiliolide A1 acts as a reversible SERCA inhibitor, not unlike 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a SERCA blocker that protects HeLa cells from ceramide-induced apoptosis (Pinton et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…The anti-phospho-ERK1 ϩ 2 (sc-7383) was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and the mAbs anti-phospho-JNK (9255S) and anti-phospho-p65 (3031S) were from New England Biolabs (Hitchin, UK). Thapsigargin and the tetracyclic C19 dilactones basiliolide A1, B, and C were isolated from Thapsia garganica as described previously (Appendino et al, 2005). BTP-2 was from Calbiochem (San Diego, CA).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations